Abarelix is a drug used to reduce the amount of testosterone made in patients with advanced symptomatic prostate cancer for which no other treatment options are available.
It belongs to the family of drugs called gonadotropin-releasing hormone (GnRH) antagonists.
Also called Plenaxis.
Status in the US
It is withdrawn from the US market in 2005 due to poor sales and significant allergic reactions.
It is marketed in Germany and Netherlands
Advanced prostate cancer
Latest research - Abarelix
Abarelix is part of WikiMD's free ^articles!
^Abarelix (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.